CN Stock MarketDetailed Quotes

Shanghai Shenqi Pharmaceutical Investment Management (600613)

Watchlist
  • 6.39
  • +0.11+1.75%
Trading Apr 15 13:52 CST
3.41BMarket Cap54.62P/E (TTM)

Shanghai Shenqi Pharmaceutical Investment Management (600613) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Main business960.31M99.94%
Other business536.46K0.06%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing1.2B58.78%
Pharmaceutical commerce844.58M41.22%

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
East China region1.17B56.99%
Central China252.33M12.32%
Southwest area153.61M7.50%
North China140.25M6.85%
Northeast area129.88M6.34%
South China97.12M4.74%
Northwest region88.39M4.31%
Exit19.58M0.96%
Total special adjustments--
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
US President Trump stated in a recent interview that the US war with Iran has 'ended.' According to Axios, Pakistan, Egypt, and Turkey have Show More